Theobromine
CARDIOVASCULAR SYSTEM
Also known as: 3,7-Dimethylxanthine, diurobromine, teobromin, theosalvose, theostene
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Theobromine is a drug catalogued in DrugCentral.
- ATC code: C03BD01 (Xanthine derivatives).
- Molecular formula: C7H8N4O2; molecular weight 180.17 g/mol.
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C03BD01 | CARDIOVASCULAR SYSTEM › DIURETICS › LOW-CEILING DIURETICS, EXCL. THIAZIDES › Xanthine derivatives |
R03DA07 | RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › Xanthines |
R03DA57 | RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › Xanthines |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Adulterated product | 280.6 |
| Accidental death | 206.0 |
| Toxicity to various agents | 157.0 |
| Drug interaction | 78.9 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Theobromine is on its molecule page.
| Molecular formula | C7H8N4O2 |
|---|---|
| Molecular weight | 180.17 g/mol |
| CAS number | 83-67-0 |
| InChIKey | YAPQBXQYLJRXSA-UHFFFAOYSA-N |
| PubChem CID | 5429 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is the chemical formula of Theobromine?
Theobromine has the molecular formula C7H8N4O2 and a molecular weight of 180.17 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2618 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1114 — compound record and bioactivity
- PubChem CID 5429 — chemical identifiers
- DrugBank DB01412 — drug record
- FDA UNII OBD445WZ5P — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.